FDA DEVICE FACTS
ECG Analysis Software (AiTiALVSD)
Medical AI Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
AiTiALVSD is a software that utilizes artificial intelligence (AI) algorithms to support diagnosis of Left Ventricular Systolic Dysfunction (LVSD). AiTiALVSD is intended to assess LVSD, defined as a Left Ventricular Ejection Fraction (LVEF) less than or equal to 40%, in adults at risk for heart failure using 12-lead ECG data. AiTiALVSD is meant for use in professional medical facilities by qualified clinicians. The software is indicated for use on adults only. When the results (High or Low) from AiTiALVSD are applied in a clinical setting to an individual patient's ECG data, they can assist in clinical decision-making regarding patient diagnosis. However, these results should be used in conjunction with other clinical data and should not be the sole determinant for a clinical diagnosis. The target population includes adults at risk for heart failure. This population includes, but is not limited to, individuals with coronary artery disease, diabetes mellitus, cardiomyopathies, hypertension, obesity; history of myocardial infarction; aortic stenosis; atrial fibrillation; exposure to cardiotoxic pharmaceutical therapies; cardiac hypertrophy evident in chest X-rays; and postpartum women. Additionally, AiTiALVSD should not be used on ECGs with a paced rhythm.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。